000 | 00900 a2200277 4500 | ||
---|---|---|---|
005 | 20250514054541.0 | ||
264 | 0 | _c20030121 | |
008 | 200301s 0 0 eng d | ||
022 | _a0098-7484 | ||
024 | 7 |
_a10.1001/jama.289.2.227 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorens, David M | |
245 | 0 | 0 |
_aInfluenza-related mortality: considerations for practice and public health. _h[electronic resource] |
260 |
_bJAMA _cJan 2003 |
||
300 |
_a227-9 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 | _aCost of Illness |
650 | 0 | 4 | _aHealth Policy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfluenza Vaccines |
650 | 0 | 4 |
_aInfluenza, Human _xmortality |
650 | 0 | 4 | _aPatient Education as Topic |
650 | 0 | 4 | _aRisk |
773 | 0 |
_tJAMA _gvol. 289 _gno. 2 _gp. 227-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.289.2.227 _zAvailable from publisher's website |
999 |
_c12320095 _d12320095 |